载脂蛋白B 来源于人血浆

载脂蛋白 B 是低密度脂蛋白（LDL）中最主要的蛋白质成分。在正常血浆中，载脂蛋白 B 的浓度为每 100 毫升 90 毫克。载脂蛋白 B 的作用被认为包括：稳定脂质乳剂、充当酶促反应的辅因子与调节剂、协助脂质排出细胞外，以及将脂质转运至靶器官。载脂蛋白 B 水平与冠心病风险呈正相关。相较于低密度脂蛋白（LDL）水平，载脂蛋白 B 水平可能是更灵敏的心血管疾病风险预测指标，且其准确检测无需空腹。 载脂蛋白 B 存在两种形式，分别是载脂蛋白 B-100（Apo B-100）和载脂蛋白 B-48（Apo B-48）： 载脂蛋白 B-100 存在于极低密度脂蛋白（VLDL）和低密度脂蛋白（LDL）中，由肝脏合成； 载脂蛋白 B-48 存在于乳糜微粒（chylomicrons）中，起源于肠道。 所用血浆经 FDA 要求的检测显示，乙型肝炎表面抗原（HBsAg）、抗丙型肝炎病毒（抗 - HCV）、抗乙型肝炎核心抗体（抗 - HBc）均为阴性，且抗人类免疫缺陷病毒 1 型和 2 型（抗 - HIV 1 & 2）也为阴性。 Apolipoprotein B is the dominant protein constituent of LDL. The concentration of Apo B in normal plasma is 90 mg per 100 ml. Apo B is thought to stabilize lipid emulsions, serve as a cofactor and modulator of enzymatic reactions, manage export of lipids out of cells and direct lipids to target organs. Apo B levels are positively correlated with the risk of coronary disease. Apo B levels may be a more sensitive predictor of cardiovascular risk than LDL levels and do not involve fasting for accurate measurement. Two forms of Apo B exist: Apo B-100 and Apo B-48. The first is found in VLDL and LDL and is produced by the liver. The second is found in chylomicrons and originates in the intestine. Prepared from plasma shown to be non reactive for HBsAg, anti-HCV, anti-HBc, and negative for anti-HIV 1 & 2 by FDA approved tests.

No numbering system information yet

No physical and chemical property information yet

No safety information yet

No production method and use information yet

No upstream information yet

No downstream information yet

No related product information yet